BlackRock Institutional Trust’s Immune Design Corp. IMDZ Stock Holding History

BlackRock Institutional Trust’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.49M	Buy	270,334 +15,562	+6%	+$110K	﹤0.01%	3157
2016 Q3	$1.93M	Buy	254,772 +25,226	+11%	+$184K	﹤0.01%	3064
2016 Q2	$1.87M	Sell	229,546 -1,340	-0.6%	-$16.7K	﹤0.01%	3064
2016 Q1	$3M	Sell	230,886 -5,482	-2%	-$63.3K	﹤0.01%	2877
2015 Q4	$4.75M	Buy	236,368 +25,406	+12%	+$438K	﹤0.01%	2763
2015 Q3	$2.57M	Buy	210,962 +45,395	+27%	+$851K	﹤0.01%	3021
2015 Q2	$3.42M	Buy	165,567 +91,506	+124%	+$2.16M	﹤0.01%	2901
2015 Q1	$1.56M	Buy	74,061 +26,295	+55%	+$686K	﹤0.01%	3218
2014 Q4	$1.47M	Sell	47,766 -764	-2%	-$21.2K	﹤0.01%	3239
2014 Q3	$857K	Buy	+48,530	New	+$614K	﹤0.01%	3365

Other funds holding IMDZ

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock Institutional Trust's IMDZ Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Immune Design Corp. (IMDZ) stake by 6.1% in Q4 2016, buying an estimated $110K and bringing the position to 270,334 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #3157.

BlackRock Institutional Trust first reported a position in IMDZ in Q3 2014 and has held it in 10 quarters since. The position peaked at $4.75M in Q4 2015. 65 funds tracked by Wall St. Rank hold IMDZ as of Q4 2016.

BlackRock Institutional Trust held 270,334 shares of Immune Design Corp. worth $1.49M as of Q4 2016.
BlackRock Institutional Trust bought 15,562 Immune Design Corp. shares in Q4 2016, an estimated $110K.
Immune Design Corp. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3157 holding.
BlackRock Institutional Trust first reported a position in Immune Design Corp. in Q3 2014 and has held it in 10 quarters since.
BlackRock Institutional Trust's Immune Design Corp. position peaked at $4.75M in Q4 2015.
65 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.